WuXi AppTec News and Resources

WuXi AppTec’s Active Pharmaceutical Ingredient (API) manufacturing facilities in Changzhou and Taixing, China, successfully passed U.S. Food and Drug Administration (FDA) inspections in March 2025. Both sites cleared their respective reviews without a single observation, reinforcing the company’s commitment to high-quality

WuXi AppTec, a Contract Research Development and Manufacturing Organization, announced its new role as a Supplier Partner in the Pharmaceutical Supply Chain Initiative (PSCI). The partnership underlines the company’s dedication to fostering sustainability and resilience across the supply chain. The

WuXi AppTec, a global life sciences and pharmaceutical services company, announced that its Couvet, Switzerland facility has received a silver medal in the 2024 EcoVadis business sustainability ratings. This achievement places the facility in the top 9% of all companies